Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia

Detalles Bibliográficos
Autores principales: Nilsson, Malin S., Hallner, Alexander, Brune, Mats, Nilsson, Staffan, Thorén, Fredrik B., Martner, Anna, Hellstrand, Kristoffer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027927/
https://www.ncbi.nlm.nih.gov/pubmed/31853942
http://dx.doi.org/10.1111/bjh.16320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027927/
https://www.ncbi.nlm.nih.gov/pubmed/31853942
http://dx.doi.org/10.1111/bjh.16320

Ejemplares similares